Establishment of three cisplatin-resistant endometrial cancer cell lines using two methods of cisplatin exposure
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s13277-010-0133-6.pdf
Reference31 articles.
1. Tominaga S et al. Cancer mortality and morbidity statistics. Tokyo: Japan Scientific Societies; 1994.
2. Rosenberg B, VanCamp L, Krigas T. Inhibition of cell division in escherichia coli by electrolysis products from a platinum electrode. Nature. 1965;205:698–9.
3. Muss HB. Chemotherapy of metastatic endometrial cancer. Semin Oncol. 1994;21:107–13.
4. Thigpen JT, Blessing JA, Lagasse LD, DiSaia PJ, Homesley HD. Phase II trial of cisplatin as secondline chemotherapy in patients with advanced or recurrent endometrial carcinoma. A gynecologic oncology group study. Am J Clin Oncol. 1984;7:253–6.
5. Deppe G, Cohen CJ, Bruckner HW. Treatment of advanced endometrial adenocarcinoma with cis-dichlorodiammine platinum (II) after intensive prior therapy. Gynecol Oncol. 1980;10:51–4.
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Spontaneous Cell Detachment and Reattachment in Cancer Cell Lines: An In Vitro Model of Metastasis and Malignancy;International Journal of Molecular Sciences;2021-05-06
2. Activation of AXL as a Preclinical Acquired Resistance Mechanism Against Osimertinib Treatment in EGFR-Mutant Non–Small Cell Lung Cancer Cells;Molecular Cancer Research;2018-11-21
3. Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure;Journal of Visualized Experiments;2017-08-11
4. Hematologic malignancies: newer strategies to counter the BCL-2 protein;Journal of Cancer Research and Clinical Oncology;2016-04-04
5. Biological relevance of Hsp90-binding immunophilins in cancer development and treatment;International Journal of Cancer;2015-03-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3